Entyvio subcutaneous injection is now FDA approved for Crohn's disease!! #IBD #GITwitter

takeda.com/newsroom/newsr…

We are excited for our second annual virtual IBD Pharmacist Symposium Crohn's & Colitis Foundation. We want all IBD pharmacists to attend. Please share with your IBD Pharmacy Team! @GIPharmD #IBD #GItwitter

us06web.zoom.us/meeting/regist…

With CVS mandated switching of Humira to Hyrimoz there are a few pt edu to ensure success 1) Hyrimoz has shown it is safe and effective 2) Hyrimoz pen is easier to use than Humira 3) commercial patients ($0 copay card) 4) may benefit US Healthcare system! #IBD #GITwitter

Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy. pubmed.ncbi.nlm.nih.gov/38492903/

This story is heartbreaking to read. Faster turn around time for PAs is important but what we really need is appeals reform (electronic appeals submission, electronic tracking and faster review) #PAreform #insurance
npr.org/sections/healt…

One of the most impactful changes that insurers can make to streamline the prior authorization/appeal process is to have electronic appeals submission and tracking! Why are we still relying on faxes for appeal submissions?? #IBD #GITwitter #insurance

We were able to publish a review for mirikizumab for the treatment of ulcerative colitis! Summarizing monitoring, dosing and hopefully helpful for P&T reviews! Shubha Bhat, PharmD #IBD #GITwitter pubmed.ncbi.nlm.nih.gov/38344998/

Finally the FDA approval for oral budesonide (Eohilia) to treat eosinophilic esophagitis! #GITwitter

medscape.com/viewarticle/fd…

Early initiation of Rinvoq can prevent hospitalizations/be a steroid sparing approach. Our results (soon to be published) show significant delays trying to initiate, especially when forced to use outside pharmacies (18 days). We need to fix this! #IBD #GITwitter

“I think it’s really exciting in the #IBD space right now because our arsenal of tools 🛠️ is going to continue to grow,” David Choi, PharmD said at #CCCongress24 .

Check it out ⬇️

healio.com/news/gastroent…

It was such a fun time hanging out with IBD pharmacists at #CCCongress24 ! It was amazing to finally meet so many in person and to be able to have a great time together. Thank you Crohn's & Colitis Foundation for this opportunity! #IBD #GITwitter

Absolutely love working with this amazing team UChicago Digestive Diseases UChicagoIBD! Amazing mentors and friends! Noa Krugliak Cleveland, MD David T. Rubin, MD Marita Kametas joel pekow #CCCongress24

Super excited for our review on etrasimod summarizing baseline monitoring, dosing, drug interactions, etc for a practical review of therapy! Shubha Bhat, PharmD #IBD #GItwitter
pubmed.ncbi.nlm.nih.gov/38258760/

We were able to publish our data looking at combination ustekinumab + upadacitinib showing this is effective! Hopefully this can help with appealing to insurers! Yusuke Miyatani, MD David T. Rubin, MD

It was so great finally meeting you in person and can't wait to continue working with you! Nir Salomon

Super excited for the keynote address by David T. Rubin, MD at AIBD!! Combination Therapy! #AIBD2023 #aibd

This is one of the most accurate schematic for how the prior authorization process works and why it is broken. #gitwitter #ibd

So excited for this amazing session looking at the future of IBD! Visions from the crystal ball #AIBD2023 #aibd

It was amazing being able to present with Florian Rieder Christina Ha MD! #AIBD2023 #aibd

Super excited for the start of AIBD! #AIBD2023 #GITwitter Millie Long Miguel Regueiro Stephen B. Hanauer, MD